248
Views
6
CrossRef citations to date
0
Altmetric
Articles

Molecular dynamics simulation, binding free energy calculation and molecular docking of human D-amino acid oxidase (DAAO) with its inhibitors

, , , &
Pages 1167-1189 | Received 17 Jun 2013, Accepted 03 Oct 2013, Published online: 13 Jan 2014

References

  • World Health Organization (WHO). Mental health [Internet]. WHO, [cited 2013 May]. Available from: http://www.who.int/mental_health/management/schizophrenia/en/.
  • LiF, TsienJZ. Memory and the NMDA receptors. N Engl J Med. 2009;361:302–303.
  • ChenPE, GeballeMT, StansfeldPJ, JohnstonAR, YuanH, JacobAL, SnyderJP, TraynelisSF, WyllieDJ. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-d-aspartate receptors determined by site-directed mutagenesis and molecular modeling. Mol Pharmacol. 2005;67:1470–1484.
  • TsaiG, YangP, ChungLC, LangeN, CoyleJT. d-Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 1998;44:1081–1089.
  • WoloskerH. d-Serine regulation of NMDA receptor activity. Sci STKE. 2006;2006:pe41.
  • CurtiB, RonchiS, SimonettaPM. d- and l-amino acid oxidases. In chemistry and biochemistry of flavoenzyme. Vol. 3. Boca Raton, FL: CRC Press; 1992.
  • BendikovI, NadriC, AmarS, PanizzuttiR, De MirandaJ, WoloskerH, AgamG. A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophr Res. 2007;90:41–51.
  • BurnetPW, EastwoodSL, BristowGC, GodlewskaBR, SikkaP, WalkerM, HarrisonPJ. d-Amino acid oxidase activity and expression are increased in schizophrenia. Mol Psychiatry. 2008;13:658–660.
  • HashimotoK, FukushimaT, ShimizuE, KomatsuN, WatanabeH, ShinodaN, NakazatoM, KumakiriC, OkadaS, HasegawaH, ImaiK, IyoM. Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003;60:572–576.
  • MadeiraC, FreitasME, Vargas-LopesC, WoloskerH, PanizzuttiR. Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr Res. 2008;101:76–83.
  • VerrallL, WalkerM, RawlingsN, BenzelI, KewJN, HarrisonPJ, BurnetPW. d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur J Neurosci. 2007;26:1657–1669.
  • FerrarisD, DuvallB, KoYS, ThomasAG, RojasC, MajerP, HashimotoK, TsukamotoT. Synthesis and biological evaluation of d-amino acid oxidase inhibitors. J Med Chem. 2008;51:3357–3359.
  • DuplantierAJ, BeckerSL, BohanonMJ, BorzilleriKA, ChrunykBA, DownsJT, HuLY, El-KattanA, JamesLC, LiuS, LuJ, MakladN, MansourMN, MenteS, PiotrowskiMA, SakyaSM, SheehanS, SteynSJ, StrickCA, WilliamsVA, ZhangL. Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent d-amino acid oxidase (DAAO) inhibitors. J Med Chem. 2009;52:3576–3585.
  • SpareyT, AbeywickremaP, AlmondS, BrandonN, ByrneN, CampbellA, HutsonPH, JacobsonM, JonesB, MunshiS, PascarellaD, PikeA, PrasadGS, SachsN, SakatisM, SardanaV, VenkatramanS, YoungMB. The discovery of fused pyrrole carboxylic acids as novel, potent d-amino acid oxidase (DAO) inhibitors. Bioorg Med Chem Lett. 2008;18:3386–3391.
  • KawazoeT, TsugeH, ImagawaT, AkiK, KuramitsuS, FukuiK. Structural basis of d-DOPA oxidation by d-amino acid oxidase: alternative pathway for dopamine biosynthesis. Biochem Biophys Res Commun. 2007;355:385–391.
  • KawazoeT, TsugeH, PiloneMS, FukuiK. Crystal structure of human d-amino acid oxidase: context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. Protein Sci. 2006;15:2708–2717.
  • LangeJHM, VenhorstJ, van DongenMJP, FrankenaJ, BassissiF, de BruinNMWJ, BestenCd, de BeerSBA, OostenbrinkC, MarkovaN, KruseCG. Biophysical and physicochemical methods differentiate highly ligand-efficient human d-amino acid oxidase inhibitors. Eur J Med Chem. 2011;46:4808–4819.
  • HondoT, WarizayaM, NiimiT, NamatameI, YamaguchiT, NakanishiK, HamajimaT, HaradaK, SakashitaH, MatsumotoY, OritaM, TakeuchiM. 4-Hydroxypyridazin-3(2H)-one derivatives as novel d-amino acid oxidase inhibitors. J Med Chem. 2013;56:3582–3592.
  • CaseDA, DardenTA, CheathamI, Cheatham IiiTE, SimmerlingCL, WangJ, DukeRE, LuoR, MerzKM, PearlmanDA, CrowleyM, WalkerRC, ZhangW, WangB, HayikS, RoitbergA, SeabraG, WongKF, PaesaniF, WuX, BrozellS, TsuiV, GohlkeH, YangL, TanC, MonganJ, HornakV, CuiG, BerozaP, MathewsDH, SchafmeisterC, RossWS, KollmanPA. AMBER 10. San Francisco, CA: University of California; 2006.
  • HornakV, AbelR, OkurA, StrockbineB, RoitbergA, SimmerlingC. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins Struct Funct Bioinf. 2006;65:712–725.
  • WangJ, WolfRM, CaldwellJW, KollmanPA, CaseDA. Development and testing of a general Amber force field. J Comput Chem. 2004;25:1157–1174.
  • BaylyCI, CieplakP, CornellWD, KollmanPA. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges – the RESP model. J Phys Chem. 1993;97:10269–10280.
  • JorgensenWL, ChandrasekharJ, MaduraJ, KleinML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926–935.
  • PastorRW, BrooksBR, SzaboA. An analysis of the accuracy of Langevin and molecular dynamics algorithms. Mol Phys. 1988;65:1409–1419.
  • RyckaertJP, CiccottiG, BerendsenHJC. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys. 1977;23:327–341.
  • DardenT, YorkD, PedersenL. Particle mesh Ewald – an N.log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089–10092.
  • AmadeiA, LinssenAB, BerendsenHJ. Essential dynamics of proteins. Proteins Struct Funct Bioinf. 1993;17:412–425.
  • AmadeiA, LinssenAB, de GrootBL, van AaltenDM, BerendsenHJ. An efficient method for sampling the essential subspace of proteins. J Biomol Struct Dyn. 1996;13:615–625.
  • YamaguchiH, van AaltenDM, PinakM, FurukawaA, OsmanR. Essential dynamics of DNA containing a cis.syn cyclobutane thymine dimer lesion. Nucleic Acids Res. 1998;26:1939–1946.
  • van AaltenDM, FindlayJB, AmadeiA, BerendsenHJ. Essential dynamics of the cellular retinol-binding protein – evidence for ligand-induced conformational changes. Protein Eng. 1995;8:1129–1135.
  • MeyerT, Ferrer-CostaC, PerezA, RuedaM, Bidon-ChanalA, LuqueFJ, LaughtonCA, OrozcoM. Essential dynamics: a tool for efficient trajectory compression and management. J Chem Theory Comput. 2006;2:251–258.
  • TeeterMM, CaseDA. Harmonic and quasiharmonic descriptions of crambin. J Phys Chem. 1990;94:8091–8097.
  • RajeM, HinN, DuvallB, FerrarisDV, BerryJF, ThomasAG, AltJ, RojasC, SlusherBS, TsukamotoT. Synthesis of kojic acid derivatives as secondary binding site probes of d-amino acid oxidase. Bioorg Med Chem Lett. 2013;23:3910–3913.
  • JonesG, WillettP, GlenRC. Molecular recognition of receptor-sites using a genetic algorithm with a description of desolvation. J Mol Biol. 1995;245:43–53.
  • JonesG, WillettP, GlenRC, LeachAR, TaylorR. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997;267:727–748.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.